The estimated likelihood ratios for predicting BRCA1 or BRCA2 mutation status defined by breast tumor ER-grade phenotype, adjusted for country by using stratified analysis, are shown in Table 2. The gene discussed is BRCA2; the disease is breast neoplasm.